Evidence map›Paper›PMID 23919929›Full record

ReviewBiochemical pharmacology2013

Vitamin E: a dark horse at the crossroad of cancer management.

Eduardo Cardenas, Rita Ghosh

Open access · greenAbstract readReview
In one paragraph

Review in Biochemical pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 82 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Eduardo CardenasDepartment of Urology, School of Medicine, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Rita Ghosh
The University of Texas Health Science Center at San Antonio · US

Funding

Cancer Biology Training ProgramT32CA148724 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Pei Wang, Feng-Chun Yang · 2011 to 2026
$3.3M
Oxidative stress in prostate cancer: Efficacy of antioxidants in Nkx3.1; Pten modR01CA149516 · NCI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI GHOSH, RITA · 2010 to 2014
$1.6M
NCI NIH HHS 1T32CA148724NCI NIH HHS 5R01 CA149516NCI NIH HHS R01 CA149516NCI NIH HHS T32 CA148724
6 · The paper itself

Abstract

It appears that the story on vitamin E and its role in human health remains incomplete. It is apparent that vitamin E supplementation involves many variables, some of which include its uptake from the intestine, the preference for α-tocopherol, transport by tocopherol specific proteins and lipid transporters and the differential metabolism of different vitamin E isoforms. The fundamental differences within population genetics can have significant implications for the effect that dietary supplementation might have on human health. When evaluating the efficacy of vitamin E prophylactic or therapeutic use in previous and future studies, it is critical to consider dosage to be administered, form of vitamin E and source (such as whether from synthetic or purified from natural sources). Further studies are needed to determine the effects of all vitamin E isoforms on cell growth, tumorigenicity, to clarify its possible use as an adjuvant to existing chemotherapeutics. The Alpha-Tocopherol, Beta Carotene (ATBC) Cancer Prevention Study Group and Selenium and Vitamin E Cancer Prevention Trial (SELECT) studies along with the numerous studies of vitamin E should help guide the next chapter of vitamin E research.

Indexed as

AnimalsAntioxidantsDietary SupplementsDrug Screening Assays, AntitumorHumansNeoplasmsTocotrienolsVitamin EAntioxidantsTocotrienolsVitamin EABCA1alpha-tocopherol, beta-caroteneAntioxidantATBCATP-binding cassette A1Cancer preventionCancer therapyHDLhigh density lipoproteinsLDLlow density lipoproteinsNiemann-Pick C1-like 1non-small cell lung cancerNPC1L1NSCLCPKCpolyunsaturated fatty acidsprotein kinase CPUFAreactive oxygen speciesROSscavenger receptor class B type 1SELECTselenium and vitamin E cancer prevention trialSR-BITAPTocopherolTocopherol associated proteintocopherol transfer proteinTocotrienoltocotrienol rich fractionTRFTTPvery low density lipoproteinVitamin E transport proteinsVLDL

Identifiers

PMID23919929
PMCPMC4100069
OpenAlexW1977565705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.